Cargando…
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and leads to the poorest patient outcomes despite surgery and chemotherapy treatment. Exploring new molecular mechanisms of TNBC that could lead to the development of novel molecular targets are critically...
Autores principales: | Tan, Zheqiong, Deme, Pragney, Boyapati, Keerti, Claes, Britt S. R., Duivenvoorden, Annet A. M., Heeren, Ron M. A., Tressler, Caitlin M., Haughey, Norman James, Glunde, Kristine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683240/ https://www.ncbi.nlm.nih.gov/pubmed/38017485 http://dx.doi.org/10.1186/s13058-023-01742-0 |
Ejemplares similares
-
A multimodal pipeline using NMR spectroscopy and MALDI-TOF mass spectrometry imaging from the same tissue sample
por: Tressler, Caitlin M., et al.
Publicado: (2023) -
Primary breast tumor induced extracellular matrix remodeling in premetastatic lungs
por: Cai, Ruoqing, et al.
Publicado: (2023) -
Targeting Phospholipid Metabolism in Cancer
por: Cheng, Menglin, et al.
Publicado: (2016) -
Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer
por: Pavuluri, KowsalyaDevi, et al.
Publicado: (2022) -
Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis
por: Ščupáková, Klára, et al.
Publicado: (2021)